NS Partners Ltd Raises Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

NS Partners Ltd lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 73,518 shares of the medical equipment provider's stock after acquiring an additional 1,632 shares during the period. Intuitive Surgical accounts for 1.5% of NS Partners Ltd's portfolio, making the stock its 22nd largest position. NS Partners Ltd's holdings in Intuitive Surgical were worth $36,117,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the company. Healthcare of Ontario Pension Plan Trust Fund raised its stake in Intuitive Surgical by 10,606.9% in the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 12,420 shares of the medical equipment provider's stock valued at $4,957,000 after buying an additional 12,304 shares during the last quarter. Crewe Advisors LLC acquired a new position in shares of Intuitive Surgical during the first quarter valued at about $161,000. CreativeOne Wealth LLC raised its position in shares of Intuitive Surgical by 41.2% in the 1st quarter. CreativeOne Wealth LLC now owns 2,324 shares of the medical equipment provider's stock valued at $927,000 after purchasing an additional 678 shares during the last quarter. Freestone Capital Holdings LLC boosted its stake in Intuitive Surgical by 2.9% in the 1st quarter. Freestone Capital Holdings LLC now owns 7,471 shares of the medical equipment provider's stock worth $2,982,000 after purchasing an additional 208 shares in the last quarter. Finally, Axxcess Wealth Management LLC grew its position in Intuitive Surgical by 18.1% during the 1st quarter. Axxcess Wealth Management LLC now owns 10,551 shares of the medical equipment provider's stock worth $4,211,000 after purchasing an additional 1,618 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently commented on ISRG. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research note on Friday, October 18th. Piper Sandler reaffirmed an "overweight" rating and set a $538.00 target price (up previously from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Evercore ISI restated a "cautious" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Redburn Atlantic upgraded Intuitive Surgical from a "neutral" rating to a "buy" rating and lifted their price objective for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Finally, Mizuho raised their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $524.61.

Insider Buying and Selling

In related news, insider Jamie Samath sold 269 shares of the stock in a transaction on Monday, November 11th. The stock was sold at an average price of $539.89, for a total value of $145,230.41. Following the transaction, the insider now owns 8,757 shares of the company's stock, valued at $4,727,816.73. This represents a 2.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, General Counsel Gary Loeb sold 300 shares of the firm's stock in a transaction on Monday, September 9th. The shares were sold at an average price of $475.00, for a total value of $142,500.00. Following the completion of the sale, the general counsel now owns 1,595 shares in the company, valued at approximately $757,625. This represents a 15.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 91,178 shares of company stock valued at $45,897,071 in the last three months. 0.80% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Up 0.4 %

ISRG stock traded up $2.15 during mid-day trading on Wednesday, hitting $540.97. 615,562 shares of the company were exchanged, compared to its average volume of 1,455,254. The business has a fifty day simple moving average of $501.42 and a 200-day simple moving average of $460.69. The firm has a market capitalization of $192.68 billion, a P/E ratio of 86.63, a PEG ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $304.50 and a 12-month high of $544.38.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Research analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.